These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29374392)

  • 1. p53 expression and subcellular survivin localization improve the diagnosis and prognosis of patients with diffuse astrocytic tumors.
    Faccion RS; Bernardo PS; de Lopes GPF; Bastos LS; Teixeira CL; de Oliveira JA; Fernandes PV; Dubois LG; Chimelli L; Maia RC
    Cell Oncol (Dordr); 2018 Apr; 41(2):141-157. PubMed ID: 29374392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survivin subcellular localization in high-grade astrocytomas: simultaneous expression in both nucleus and cytoplasm is negative prognostic marker.
    Saito T; Arifin MT; Hama S; Kajiwara Y; Sugiyama K; Yamasaki F; Hidaka T; Arita K; Kurisu K
    J Neurooncol; 2007 Apr; 82(2):193-8. PubMed ID: 17151933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of survivin in astrocytic tumors: correlation with malignant grade and prognosis.
    Kajiwara Y; Yamasaki F; Hama S; Yahara K; Yoshioka H; Sugiyama K; Arita K; Kurisu K
    Cancer; 2003 Feb; 97(4):1077-83. PubMed ID: 12569609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survivin, caspase-3 and MIB-1 expression in astrocytic tumors of various grades.
    Lebelt A; Rutkowski R; Och W; Jaczun K; Dziemiańczyk-Pakieła D; Milewski R; Mariak Z; Reszeć J
    Adv Med Sci; 2016 Sep; 61(2):237-243. PubMed ID: 26995334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 protein overexpression in astrocytic neoplasms.
    Cho MY; Jung SH; Kim TS
    Yonsei Med J; 1995 Dec; 36(6):521-6. PubMed ID: 8599254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic indicators in a range of astrocytic tumours: an immunohistochemical study with Ki-67 and p53 antibodies.
    Ellison DW; Steart PV; Bateman AC; Pickering RM; Palmer JD; Weller RO
    J Neurol Neurosurg Psychiatry; 1995 Oct; 59(4):413-9. PubMed ID: 7561922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Manganese superoxide dismutase (MnSOD) is a malignant astrocytoma specific biomarker and associated with adverse prognosis in p53 expressing glioblastoma.
    Shwetha SD; Shastry AH; Arivazhagan A; Santosh V
    Pathol Res Pract; 2016 Jan; 212(1):17-23. PubMed ID: 26616112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical pattern of P53 protein in human astrocytic tumors.
    Howng SL; Hwang SL; Chai CY; Lin HJ
    Kaohsiung J Med Sci; 1996 May; 12(5):279-84. PubMed ID: 8676433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of P-glycoprotein, p53, and survivin expression in renal cell carcinoma.
    Baytekin F; Tuna B; Mungan U; Aslan G; Yorukoglu K
    Urol Oncol; 2011; 29(5):502-7. PubMed ID: 19945306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 protein alterations in adult astrocytic tumors and oligodendrogliomas.
    Nayak A; Ralte AM; Sharma MC; Singh VP; Mahapatra AK; Mehta VS; Sarkar C
    Neurol India; 2004 Jun; 52(2):228-32. PubMed ID: 15269478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of survivin and DNA topoisomerase IIα in diffuse and anaplastic astrocytomas.
    Varughese RK; Skjulsvik AJ; Torp SH
    Pathol Res Pract; 2017 Apr; 213(4):339-347. PubMed ID: 28214203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survivin and laryngeal carcinoma prognosis: nuclear localization and expression of splice variants.
    Marioni G; Agostini M; Bedin C; Blandamura S; Stellini E; Favero G; Lionello M; Giacomelli L; Burti S; D'Angelo E; Nitti D; Staffieri A; De Filippis C
    Histopathology; 2012 Aug; 61(2):247-56. PubMed ID: 22416874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.
    Hartmann C; Hentschel B; Wick W; Capper D; Felsberg J; Simon M; Westphal M; Schackert G; Meyermann R; Pietsch T; Reifenberger G; Weller M; Loeffler M; von Deimling A
    Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 abnormality and tumor invasion in patients with malignant astrocytoma.
    Momota H; Narita Y; Matsushita Y; Miyakita Y; Shibui S
    Brain Tumor Pathol; 2010 Oct; 27(2):95-101. PubMed ID: 21046311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KLF4 expression and apoptosis-related markers in gastric cancer.
    Krstic M; Stojnev S; Jovanovic L; Marjanovic G
    J BUON; 2013; 18(3):695-702. PubMed ID: 24065485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of apoptosis and its related protein in astrocytic tumors.
    Takekawa Y; Sawada T; Sakurai I
    Brain Tumor Pathol; 1999; 16(1):11-6. PubMed ID: 10532418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of the Epstein-Barr virus, p53, Bcl-2, and survivin in nasopharyngeal cancer.
    Yip KW; Shi W; Pintilie M; Martin JD; Mocanu JD; Wong D; MacMillan C; Gullane P; O'Sullivan B; Bastianutto C; Liu FF
    Clin Cancer Res; 2006 Oct; 12(19):5726-32. PubMed ID: 17020977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis and proliferation: correlation with p53 in astrocytic tumours.
    Sarkar C; Karak AK; Nath N; Sharma MC; Mahapatra AK; Chattopadhyay P; Sinha S
    J Neurooncol; 2005 Jun; 73(2):93-100. PubMed ID: 15981097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of histomolecular subgroups of adult anaplastic (WHO Grade III) gliomas: applying the 'integrated' diagnosis approach.
    Rajmohan KS; Sugur HS; Shwetha SD; Ramesh A; Thennarasu K; Pandey P; Arivazhagan A; Santosh V
    J Clin Pathol; 2016 Aug; 69(8):686-94. PubMed ID: 26743027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell cycle aberration in ameloblastoma and adenomatoid odontogenic tumor: As evidenced by the expression of p53 and survivin.
    Shaikh Z; Niranjan KC
    Indian J Dent Res; 2015; 26(6):565-70. PubMed ID: 26888232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.